Trial
NCT06495307
RHPRG4 FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Lubris Bio Pty Ltd
Collaborators
Lubris, LLC; Sydney Eye Hospital
Condition
Ocular Graft-versus-host Disease
Intervention
rhPRG4
Why stopped
Efficacy signal substantial enough to more to larger study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-21